NeoGenomics Inc. Announces Partnership with Lilly for Lung C

25.04.2022 - FT. MYERS, FL / ACCESSWIRE / April 25, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today that they are partnering with Eli Lilly and ... Seite 1

Related Keywords

Derek Lyle , Anthony Nino Sireci , Clinical Division Of Neogenomics , Diagnostics Development , Lilly Lung Cancer Sponsored Testing Program , Chief Medical Officer , Clinical Division , Generation Sequencing , Vice President , Clinical Biomarkers , Loxo Oncology , Neogenomics ,